Volume 16, Issue 4 pp. 157-161
Research Article

Racial differences in psychotic symptoms among combat veterans with PTSD

B. Christopher Frueh Ph.D.

Corresponding Author

B. Christopher Frueh Ph.D.

Medical University of South Carolina, Veterans Affairs Medical Center Charleston, South Carolina

Mental Health Service (116), Veterans Affairs Medical Center, 109 Bee Street, Charleston, SC 29401-5799Search for more papers by this author
Mark B. Hamner M.D.

Mark B. Hamner M.D.

Medical University of South Carolina, Veterans Affairs Medical Center Charleston, South Carolina

Search for more papers by this author
Jeffrey A. Bernat Ph.D.

Jeffrey A. Bernat Ph.D.

Medical University of South Carolina, Veterans Affairs Medical Center Charleston, South Carolina

Search for more papers by this author
Samuel M. Turner Ph.D.

Samuel M. Turner Ph.D.

University of Maryland, College Park, Maryland

Search for more papers by this author
Terence M. Keane Ph.D.

Terence M. Keane Ph.D.

Boston University School of Medicine, Veteran Affairs Medical Center, Boston, Massachusetts

Search for more papers by this author
George W. Arana Ph.D.

George W. Arana Ph.D.

Medical University of South Carolina, Veterans Affairs Medical Center Charleston, South Carolina

Search for more papers by this author
First published: 18 December 2002
Citations: 27

Portions of this article were presented at the American Psychiatric Association 2002 Annual Meeting, Philadelphia, Pennsylvania.

Abstract

We tested the hypothesis that race may influence clinical presentation and symptomatology in combat veterans with posttraumatic stress disorder (PTSD). African-American and Caucasian veterans were administered the Psychotic Screen Module of the Structured Clinical Interview for DSM, Minnesota Multiphasic Personality Inventory-2 (MMPI-2), and other psychometric measures at a Veterans Affairs outpatient PTSD clinic. Subjects were consecutive referrals who were not matched for level of combat trauma or preexisting trauma; however, there were no group differences in other relevant demographic or diagnostic variables. Significant racial differences, with modest effect sizes, were found on clinician ratings of psychotic symptoms, MMPI-2 scale 6 (“paranoia”), and a measure of dissociation. No significant differences were found for the MMPI-2 scale 8 (“schizophrenia”), or on measures that might suggest comorbid depression or anxiety. African-Americans with PTSD endorsed more items suggesting positive symptoms of psychosis, without higher rates of primary psychosis, depression, or anxiety than Caucasians. Depression and Anxiety 16:157–161, 2002. © 2002 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.